Lipid Management
The latest information on HDL and LDL cholesterol, metabolic syndrome, statins, triglycerides, and more, drawn from across our primary care and specialty care areas. Sign up now for monthly e-mail alerts on new content.
SUMMARY AND COMMENT
Medicare Part D, Prescription Drug Spending, and Total Medical Spending
- July 1, 2009
- Harlan M. Krumholz, MD, SM
- Cardiology
In patients with little or no drug coverage before Part D enactment, additional drug costs during the program’s first 2 years were offset by reductions in other medical costs.
- Reviewing:
- Zhang Y et al. N Engl J Med 2009 Jul 2; 361:52
SUMMARY AND COMMENT
More Tofu, Please?
- June 24, 2009
- JoAnne M. Foody, MD
- Cardiology
In a small randomized, controlled study, a low-carbohydrate, plant-based diet improved lipid measures more than a high-carbohydrate, low-fat diet. CME
- Reviewing:
- Jenkins DJA et al. Arch Intern Med 2009 Jun 8; 169:1046
SUMMARY AND COMMENT
An Herbal Option for Statin-Intolerant Patients?
- June 17, 2009
- Joel M. Gore, MD
- Cardiology
A supplement of red yeast rice outperforms placebo in a small randomized trial.
- Reviewing:
- Becker DJ et al. Ann Intern Med 2009 Jun 16; 150:830
SUMMARY AND COMMENT
Rapid Weight Gain in Early Infancy Increases Risk for Cardiovascular Disease and DiabetesFree
- June 10, 2009
- F. Bruder Stapleton, MD
- Pediatrics and Adolescent Medicine
Infants with rapid weight gain had significantly greater body fat and waist circumference and reduced insulin sensitivity as adults, compared with infants with slow weight gain.
- Reviewing:
- Leunissen RWJ et al. JAMA 2009 Jun 3; 301:2234
SUMMARY AND COMMENT
Prevention of Death After Stroke
- May 26, 2009
- Paul S. Mueller, MD, MPH, FACP
- General Medicine
Only a quarter of British stroke patients (age, 
50) received recommended drug combinations.
- Reviewing:
- Raine R et al. BMJ 2009 Apr 16; 338:b1279
SUMMARY AND COMMENT
U.S. Trends in Cardiovascular Disease and Diabetes, 1999 Through 2006
- May 13, 2009
- Joel M. Gore, MD
- Cardiology
Although racial and socioeconomic disparities in disease control persist, insurance coverage appears to narrow the gaps.
- Reviewing:
- McWilliams JM et al. Ann Intern Med 2009 Apr 21; 150:505
SUMMARY AND COMMENT
Lipid Changes Differ Within HIV Drug Classes
- May 11, 2009
- Paul E. Sax, MD
- HIV/AIDS
In a pooled analysis of clinical trials, tenofovir-based therapies and those containing efavirenz or ritonavir-boosted atazanavir, darunavir, or saquinavir had the most favorable effects on plasma lipids.
- Reviewing:
- Hill A et al. HIV Clin Trials 2009 Jan/Feb; 10:1
SUMMARY AND COMMENT
Independent Effects of LDL Cholesterol and hsCRP Lowering in the JUPITER Trial
- April 23, 2009
- Bruce Soloway, MD
- General Medicine
Greater hsCRP reductions correlated with improved cardiovascular outcomes.
- Reviewing:
- Ridker PM et al. Lancet 2009 Apr 4; 373:1175
SUMMARY AND COMMENT
Secondary Prevention of Cardiovascular Events in Daily Practice
- April 22, 2009
- Beat J. Meyer, MD
- Cardiology
A longitudinal analysis of cross-sectional study results reveals an urgent need for effective lifestyle management.
- Reviewing:
- Kotseva K et al. Lancet 2009 Mar 14; 373:929
SUMMARY AND COMMENT
Statins and Venous Thrombosis
- April 14, 2009
- David Green, MD, PhD
- Oncology and Hematology
Recent studies confirm that statins lower risk for VT and suggest that the agents could aid in managing venous disease.
- Reviewing:
- Ramcharan AS et al. J Thromb Haemost 2009 Apr; 7:514
